Search Results - "Reiss, A B"

Refine Results
  1. 1

    Oxysterol derivatives of cholesterol in neurodegenerative disorders by Jeitner, T M, Voloshyna, I, Reiss, A B

    Published in Current medicinal chemistry (01-04-2011)
    “…Cholesterol is essential to the functions of the brain, which contains approximately 20% of the body's stores of this sterol. Most brain cholesterol is found…”
    Get more information
    Journal Article
  2. 2

    Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function by Reiss, A. B., Saeedullah, U., Grossfeld, D. J., Glass, A. D., Pinkhasov, A., Katz, A. E.

    Published in Clinical & translational oncology (01-05-2022)
    “…Prostate cancer is the second most common form of cancer in men. For advanced, high risk prostate cancer, androgen deprivation therapy (ADT) is the preferred…”
    Get full text
    Journal Article
  3. 3

    Effect of inhibition of interleukin-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages by Voloshyna, I., Mounessa, J., Carsons, S. E., Reiss, A. B.

    Published in Clinical and experimental dermatology (01-04-2016)
    “…Summary Background Leptin, an adipocyte‐derived circulating cytokine that signals nutritional status, may play a role in the development of psoriasis and its…”
    Get full text
    Journal Article
  4. 4

    Immune complexes and IFN-γ decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages by Reiss, Allison B., Awadallah, Nahel W., Malhotra, Sandeep, Montesinos, M. Carmen, Chan, Edwin S.L., Javitt, Norman B., Cronstein, Bruce N.

    Published in Journal of lipid research (01-11-2001)
    “…The enzyme cholesterol 27-hydroxylase, expressed by arterial endothelium and monocytes/macrophages, is one of the first lines of defense against the…”
    Get full text
    Journal Article
  5. 5

    Plasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on atherogenicity by Voloshyna, I., Mucci, T., Sher, J., Fonacier, L. S., Littlefield, M. J., Carsons, S., Reiss, A. B.

    Published in Clinical and experimental allergy (01-10-2015)
    “…Summary Objective Interleukin (IL)‐33 has been associated with atopic and inflammatory conditions. IL‐33 may be atheroprotective inducing a Th1‐to‐Th2…”
    Get full text
    Journal Article
  6. 6

    Sterol 27-hydroxylase: high levels of activity in vascular endothelium by Reiss, A B, Martin, K O, Javitt, N B, Martin, D W, Grossi, E A, Galloway, A C

    Published in Journal of lipid research (01-06-1994)
    “…Sterol 27-hydroxylase activity in bovine aortic endothelial (BAE) cells in culture has been compared with that in HepG2 cells and in Chinese hamster ovary…”
    Get full text
    Journal Article
  7. 7

    7 alpha-hydroxylation of 27-hydroxycholesterol: biologic role in the regulation of cholesterol synthesis by Martin, K O, Reiss, A B, Lathe, R, Javitt, N B

    Published in Journal of lipid research (01-05-1997)
    “…The report of a novel cytochrome P450 enzyme in mouse hippocampus (cyp7b) with close homology to cholesterol 7 alpha-hydroxylase led us to determine the…”
    Get full text
    Journal Article
  8. 8

    Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells by Khoa, N D, Montesinos, M C, Reiss, A B, Delano, D, Awadallah, N, Cronstein, B N

    Published in The Journal of immunology (1950) (01-10-2001)
    “…Adenosine, acting at its receptors, particularly A(2A) receptors, is a potent endogenous anti-inflammatory agent that modulates the functions and…”
    Get full text
    Journal Article
  9. 9

    Sterol 27-hydroxylase: expression in human arterial endothelium by Reiss, A B, Martin, K O, Rojer, D E, Iyer, S, Grossi, E A, Galloway, A C, Javitt, N B

    Published in Journal of lipid research (01-06-1997)
    “…Human endothelium obtained from both the aorta and the pulmonary artery has been evaluated for the presence of the messenger RNA coding for the expression of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells by Khoa, Nguyen D, Montesinos, M. Carmen, Reiss, Allison B, Delano, David, Awadallah, Nahel, Cronstein, Bruce N

    Published in The Journal of immunology (1950) (01-10-2001)
    “…Abstract Adenosine, acting at its receptors, particularly A2A receptors, is a potent endogenous anti-inflammatory agent that modulates the functions and…”
    Get full text
    Journal Article
  12. 12

    Examining Positive and Negative Perceptions of Older Workers: A Meta-Analysis by Bal, Anne C., Reiss, Abigail E. B., Rudolph, Cort W., Baltes, Boris B.

    “…Objective. This article presents an updated meta-analysis of field and laboratory studies that examine the influence of age on a number of evaluative workplace…”
    Get full text
    Journal Article
  13. 13

    Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease by Brown, 3rd, James, Theisler, Catherine, Silberman, Simone, Magnuson, Debra, Gottardi-Littell, Numa, Lee, John M, Yager, Debra, Crowley, Janet, Sambamurti, Kumar, Rahman, Mohammad M, Reiss, Allison B, Eckman, Christopher B, Wolozin, Benjamin

    Published in The Journal of biological chemistry (13-08-2004)
    “…Cholesterol is eliminated from neurons by oxidization, which generates oxysterols. Cholesterol oxidation is mediated by the enzymes cholesterol 24-hydroxylase…”
    Get full text
    Journal Article
  14. 14

    COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages by Voloshyna, Iryna, Kasselman, Lora J, Carsons, Steven E, Littlefield, Michael J, Gomolin, Irving H, De Leon, Joshua, Reiss, Allison B

    Published in Journal of investigative medicine (01-03-2017)
    “…It is the second decade of controversy regarding the cardiovascular effects of cyclo-oxygenase-2 (COX-2) inhibitors. At this time, celecoxib is the only…”
    Get full text
    Journal Article
  15. 15

    11: THE ADENOSINE A2A RECEPTOR AGONIST UK-432,097 STIMULATES ANTI-ATHEROGENIC REVERSE CHOLESTEROL TRANSPORT PROTEINS IN THP-1 HUMAN MACROPHAGES by Moosa, S, Voloshyna, I, Siegart, NM, De Leon, J, Carsons, SE, Kasselman, LJ, Littlefield, MJ, Reiss, AB

    Published in Journal of investigative medicine (01-03-2016)
    “…Purpose of StudyMethotrexate (MTX) is an anti-rheumatic drug with atheroprotective properties mediated through adenosine release and activation of the…”
    Get full text
    Journal Article
  16. 16

    10: CHOLESTEROL FLUX PATHWAY ABNORMALITIES INDUCED BY PLASMA FROM PATIENTS WITH CHRONIC KIDNEY DISEASE by Miyawaki, N, Daccueil, F, Siegart, NM, Mattana, J, Voloshyna, I, Kasselman, LJ, De Leon, J, Reiss, AB

    Published in Journal of investigative medicine (01-03-2016)
    “…Purpose of StudyChronic kidney disease (CKD) is a known risk factor for cardiovascular disease (CVD). Patients with CKD have a high prevalence of…”
    Get full text
    Journal Article
  17. 17

    1: COMPARATIVE EFFECT OF SELECTIVE AND NON-SELECTIVE COX-2 INHIBITORS ON LIPID ACCUMULATION IN HUMAN MACROPHAGES by Kasselman, LJ, Voloshyna, I, Littlefield, MJ, Siegart, N, Carsons, SE, Gomolin, I, De Leon, J, Reiss, AB

    Published in Journal of investigative medicine (01-03-2016)
    “…Purpose of Study It is the second decade of controversy regarding the cardiovascular (CV) effects of cycloxygenase-2 (COX-2) inhibitors. COX-2 inhibitors…”
    Get full text
    Journal Article
  18. 18

    MP1: CORRECTING ATHEROGENIC EFFECTS OF LUPUS PLASMA ON MACROPHAGES WITH RESVERATROL AND MYCOPHENOLATE by Siegart, NM, Voloshyna, I, DeLeon, J, Carsons, SE, Teboul, I, Kasselman, LJ, Mattana, J, Reiss, AB

    Published in Journal of investigative medicine (01-03-2016)
    “…Purpose of StudyPremature atherosclerosis with coronary artery disease is a major cause of morbidity in Systemic Lupus Erythematosus (SLE). SLE patient plasma…”
    Get full text
    Journal Article
  19. 19

    3: INHIBITION OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RESTORES CHOLESTEROL EFFLUX IN THP-1 HUMAN MACROPHAGES EXPOSED TO PLASMA FROM TYPE 1 DIABETES MELLITUS PATIENTS by Corletto, JM, Accacha, S, Voloshyna, I, Siegart, N, Kasselman, L, Magana, MC, DeLeon, J, Reiss, AB

    Published in Journal of investigative medicine (01-03-2016)
    “…Purpose of StudyAdvanced glycation end products (AGE), proteins formed by nonenzymatic glycation, are prevalent in patients with diabetes mellitus (DM) and…”
    Get full text
    Journal Article
  20. 20